Tag: inhaler
-
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Condition: AsthmaInterventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: PlaceboSponsor: Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A Study to Evaluate the Relationship Between Use of Albuterol Electronic Multidose Dry Powder Inhaler (eMDPI) and Exacerbations in Patients With Asthma
Condition: AsthmaIntervention: Drug: ABS eMDPISponsor: Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.
Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Treatment A – AZD7594; Drug: Treatment B – AZD7594; Drug: Treatment C – AZD7594Sponsor: AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers.
Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Treatment A – AZD7594; Drug: Treatment B – AZD7594; Drug: Treatment C – AZD7594Sponsor: AstraZenecaNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
A 12-week, Randomized, Parallel-Group, Proof-of-Concept Study of Tulobuterol Patch and Salmeterol Inhaler as Add-on Therapy in Adult-Onset Mild-to-Moderate Asthma.
Related Articles A 12-week, Randomized, Parallel-Group, Proof-of-Concept Study of Tulobuterol Patch and Salmeterol Inhaler as Add-on Therapy in Adult-Onset Mild-to-Moderate Asthma. Clin Exp Pharmacol Physiol. 2016 Oct 8;: Authors: Inoue H, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, Takeda T, Nakaji H, Tajiri T, Iwata T, Nagasaki T, Mishima M Abstract Patch […]
-
A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)Interventions: Drug: Budesonide; Drug: FormoterolSponsor: Intech Biopharm Ltd.Completed – verified July 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
-
Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use
Condition: AsthmaInterventions: Device: ELLIPTA DPI; Device: GSK MDI; Device: AZ MDISponsor: GlaxoSmithKlineNot yet recruiting – verified June 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days
-
Glenmark Pharma launches digital inhaler for asthma patients – Times of India
Times of India Glenmark Pharma launches digital inhaler for asthma patientsTimes of IndiaGlenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, launched what the company touted as India's first Digital Dose Inhaler for asthma and pulmonary disease patients. The inhaler, branded as Digihaler, provides …Glenmark launches digital dose inhaler for asthma patientsMoneycontrol.comGlenmark's new 'digital dose inhaler' […]
-
Glenmark launches digital dose inhaler for asthma patients – Moneycontrol.com
Moneycontrol.com Glenmark launches digital dose inhaler for asthma patientsMoneycontrol.com"This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable Asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy," the Mumbai-based firm said in a statement.and more » View full post on asthma – Google News
-
Glenmark launches electronic inhaler for asthma patients – Hindu Business Line
Hindu Business Line Glenmark launches electronic inhaler for asthma patientsHindu Business Line"In the case of asthma and COPD condition, where daily preventative medication is crucial for its treatment, implication of non-adherence leads to poor control symptoms, worsening the quality of life, high mortality rate which further increases health …Glenmark launches digital dose inhaler for asthma […]